COMMUNIQUÉS West-GlobeNewswire

OKYO Pharma to Present at the H.C. Wainwright 6th Annual Ophthalmology Virtual Conference
21/07/2026
LONDON and NEW YORK, July 21, 2026 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (Nasdaq: OKYO ), a clinical-stage biopharmaceutical company developing investigational therapies for the treatment of neuropathic corneal pain ( [...]
IMUNON Reports Positive Phase 2 MRD Clinical Data for IMNN-001, Demonstrating the Successful Overcoming of Historical IL-12 Safety Barriers in Frontline Ovarian Cancer
21/07/2026
Preliminary data reinforces IMNN-001 immunotherapy’s potential for success in the rapidly recruiting Phase 3 OVATION 3 clinical trial Lower rate of minimal residual disease (MRD) Higher ctDNA clearance with IMNN-001 vs [...]
SK pharmteco and Genethon Showcase French Manufacturing Strength Behind Pivotal DMD Gene Therapy Program
21/07/2026
Ongoing support for GNT-0004 highlights the capability, readiness, and continued momentum of SK pharmteco’s viral vector operations in France as part of its global network RANCHO CORDOVA, Calif., July 21, 2026 (GLOBE [...]
Myriad Genetics Launches FirstGene® Multiple Prenatal Screen
21/07/2026
The only lab test to run four prenatal genetic screens simultaneously as early as eight weeks gestation SALT LAKE CITY, July 21, 2026 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular [...]
Nelipak Releases 2025 Sustainability Report
21/07/2026
Highlights achievements aligned to sustainability vision to “help healthcare be sustainable.” CRANSTON, R.I., July 21, 2026 (GLOBE NEWSWIRE) -- Nelipak® Corporation (“Nelipak ® ”), a leading global provider of [...]
Choosing a Shaker Bottle for Thick Pre-Workout Powders: What Actually Prevents Clumping
21/07/2026
PROMIXX set out to fix what defined the manual shaker category, replacing the wire mixing ball with the Snap-Fit Agitator: a lid-locked mixing grid Cardiff, July 21, 2026 (GLOBE NEWSWIRE) -- The Snap-Fit Agitator is an [...]
Intelligent Bio Solutions Completes Precision Testing, Strengthening FDA 510(k) Submission Package Ahead of Planned Entry into Multi-Billion-Dollar U.S. Drug Screening Market
21/07/2026
Precision testing confirms reproducibility across more than 1,600 tests, three production runs, and three independent testing sites NEW YORK, July 21, 2026 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: [...]
Rhythm Pharmaceuticals to Report Second Quarter 2026 Financial Results on Tuesday, August 4, 2026
21/07/2026
BOSTON, July 21, 2026 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming the lives of patients living with rare neuroendocrine [...]
Calidi Biotherapeutics Provides Mid-Year Corporate Update and Future Key Value Drivers
21/07/2026
Company receives positive pre-IND feedback from US FDA for CLD-401, indicating agreement on its current development strategy as it advances towards a first-in-human study; targeting dosing first patient in Q1 2027 [...]
PatientsLikeMe and Science 37 Partner to Unlock Trial Access for Interested, Eligible Patients
21/07/2026
Partnership combines trusted patient communities with flexible trial participation options to help sponsors enroll faster and retain patients. BOSTON and MORRISVILLE, N.C., July 21, 2026 (GLOBE NEWSWIRE) -- [...]
Rein Therapeutics Announces Phase 2 RENEW Trial Now Enrolling Across All Five Countries
21/07/2026
Global Expansion Complete as Germany Joins Ongoing Study of Inhaled LTI-03 in Idiopathic Pulmonary Fibrosis Company on track to report initial topline data in 2H 2026 AUSTIN, Texas, July 21, 2026 (GLOBE NEWSWIRE) -- [...]
Microbot Medical® Among Featured Companies Showcasing Novel Robotic Technologies and Digital Surgery Applications at the Society of Robotic Surgery Annual Meeting
21/07/2026
Company CEO has been a featured presenter at several recent industry events on the emergence of endovascular robotics as expert speaking opportunities raising profile of the Company throughout medtech market HINGHAM, [...]
Beacon Behavioral Partners Enters Michigan and Ohio Through Partnership with Pure Psychiatry
21/07/2026
Physician-led partnership establishes BBP's first presence in the Midwest, adding a 17-location behavioral health platform, creating a foundation for continued national growth PLANO, Texas, July 21, 2026 (GLOBE NEWSWIRE [...]
Smith+Nephew introduces expanded enterprise ASC Solutions Strategy to support growth, performance and value-based care
21/07/2026
Smith+Nephew (LSE: SN, NYSE: SNN), the global medical technology company, today announced ASC Solutions: an expanded enterprise strategy for ambulatory surgery centers (ASCs) that takes a customer-centric approach to [...]
Standard Dental Labs Announces Acquisition Capital Strategy to Support Next Phase of Florida Expansion
21/07/2026
ORLANDO, Fla., July 21, 2026 (GLOBE NEWSWIRE) -- Standard Dental Labs Inc. (OTCQB: TUTH) ("SDL" or the "Company"), a consolidator of dental laboratories throughout Florida, today announced that its Board of Directors [...]
OKYO Pharma Announces Purchase of Shares by Chairman
21/07/2026
LONDON and NEW YORK, July 21, 2026 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (Nasdaq: OKYO ), a clinical-stage biopharmaceutical company developing investigational therapies for the treatment of neuropathic corneal pain ( [...]
Bluejay Diagnostics Announces Successful Completion of Enrollment in the SYMON-II Multicenter Clinical Validation Study
21/07/2026
750 Patients Enrolled Ahead of Plan in Pivotal Study Evaluating Symphony™ IL-6 for Early Assessment of 28-Day Sepsis Mortality Risk ACTON, Mass., July 21, 2026 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (NASDAQ: BJDX [...]
BioNTech to Report Second Quarter 2026 Financial Results and Corporate Update on August 4, 2026
21/07/2026
MAINZ, Germany, July 21 , 2026 (GLOBE NEWSWIRE) – BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) will announce its financial results for the second quarter 2026 on Tuesday, August 4, 2026. Additionally, the [...]
R1 Therapeutics announces commencement of global Phase 2b trial of AP306 for hyperphosphatemia in patients on dialysis
21/07/2026
AP306 is a first-in-class pan phosphate transporter inhibitor in development as a monotherapy for hyperphosphatemia, a near-universal and serious complication in chronic kidney disease patients Study underway with first [...]

Pages